Home » Topics » Regulatory

Regulatory
RSS

Enbrel approved in E.U. for psoriasis

Oct. 5, 2004

Third indication studied for SGN-30 in new phase II trial

Sep. 29, 2004

Expanded indication for Eloxatin for early stage colon cancer treatment

Sep. 21, 2004

Nexium completes European mutual recognition procedure for new indications

Sep. 20, 2004

Vioxx approved for once-daily treatment of juvenile rheumatoid arthritis

Sep. 9, 2004

Proscar approved for new indication in Canada

Sep. 7, 2004

Clarinex syrup approved for use in children with allergies, hives

Sep. 3, 2004

sNDA submission for Merrem for complicated skin and skin structure infections

Aug. 5, 2004

Aldara receives approval for superficial basal cell carcinoma

July 20, 2004

Lyrica approved in E.U.

July 12, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...